CorVel Corporation

NASDAQ:CRVL

Insurance - Brokers

Financial Services
$88.87 -0.12%

-$0.07 today

Market cap
$4.47B
Beta
0.98
P/E (TTM)
26.9
EPS (TTM)
$2.16
52W Low $44.83High $105.51

Volume 0.26M

Average 0.22M

CRVL Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

CorVel CorporationNASDAQ: CRVL

Net Change in Cash · Q1 FY2027 · quarter ended Jun 2026

Net change in cash declines year over year

Q1 FY2027 net change in cash of $22.81M fell 27.4% year over year, behind the -23.2% change in trailing-twelve-month net change in cash. Sequentially, it rose 650.6% from the prior quarter.

Context

  • Net change in cash amounted to 6.5% of revenue in FY2026, down 0.7 pp from a year earlier.
  • Net change in cash increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -27.4% toward the trailing-twelve-month pace of -23.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$22.81M+650.6% QoQ
Last fiscal yearMar 2026
$62.49M-3.9% YoY
LTMJun 2026
$53.86M-23.2% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-27.4%——
1 year-3.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2026
62.49M USD
Year-over-year change
-3.9%

Net Change in Cash vs competitors

How CRVL compares with its peers on the latest reported figures

  • CRVL's LTM Jun 2026 net change in cash of $53.86M is the 2nd largest of the 4 companies compared; the peer median is $48.46M.
  • Its year-over-year change of -23.2% is the 3rd highest of 4, against a peer median of +102.3%.
  • Net change in cash amounts to 5.5% of revenue for CRVL, versus a peer median of 3.6%.
CRVL Competitors Peer median
Net Change in Cash for CRVL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EVHEvolent Health, Inc.LTM Mar 2026$96.78M -309.9%—5.1%
CRVLCorVel CorporationLTM Jun 2026$53.86M -23.2%—5.5%
HQYHealthEquity, Inc.LTM Jul 2026$48.46M +116.0%-7.3%3.6%
CTEVClaritev CorporationLTM Mar 2026$828K +102.3%—0.1%
Peer median (excluding CRVL) $48.46M+102.3%-7.3%3.6%

Competitors are the stored peer set for CRVL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income66.41M66.37M76.25M95.17M110.34M
Depreciation & Amortization23.92M25.12M26.25M29.54M31.76M
Deferred Income Tax2.3M(1.91M)(3.32M)(5.16M)4.78M
Stock-Based Compensation5.2M5.56M4.98M5.71M5.41M
Change in Working Capital(30.88M)(14.48M)(7.05M)(1.83M)2.52M
Accounts Receivables(18.02M)336K(17.9M)(10.46M)2.7M
Inventory00000
Accounts Payables0000(728K)
Other Working Capital(12.86M)(14.81M)10.86M8.63M546K
Other Non-Cash Items280K1.63M2.12M3.89M825K
Operating Cash Flow67.22M82.29M99.24M127.32M155.64M
Capital Expenditures(29.82M)(26.32M)(29.24M)(35.76M)(45.36M)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(29.82M)(26.32M)(29.24M)(35.76M)(45.36M)
Debt Repayment00000
Common Stock Issued00008.41M
Common Stock Repurchased(90.09M)(93.68M)(45.71M)(37.61M)(56.21M)
Dividends Paid00000
Other Financing Activities10.47M11.53M9.95M11.07M0
Financing Cash Flow(79.62M)(82.14M)(35.76M)(26.54M)(47.8M)
Effect of Forex Changes00000
Net Change in Cash(42.21M)(26.18M)34.23M65.02M62.49M
Free Cash Flow37.4M55.97M70M91.56M110.28M

CorVel Corporation

NASDAQ:CRVL

Intrinsic Alpha fair value

Locked

Current Price

$88.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.